Vol 7, Supplement 6 (September 2019): Annals of Translational Medicine

Editorial Commentary

Percutaneous ablation for renal masses
Devanshu Bansal, Rajeev Kumar
Percutaneous kidney ablation: a good option in selected cases
Samuel Weprin, Alessandro Veccia, Riccardo Autorino
Improving biochemical markers for disorders of N-glycosylation
Hudson H. Freeze
Clinical dilemmas in predicting the progression of pre-clinical hypertrophic cardiomyopathy—is MRI strain the solution?
Jay Ramchand, Milind Y. Desai
Telemedicine for infectious disease care—how do we measure the true value?
Ramya Sita Palacholla, Joseph C. Kvedar
Mesenchymal stromal cells for the treatment of osteoarthritis of knee joint: context and perspective
Pawan Kumar Gupta, Charan Thej
Stereotactic body radiotherapy for oligometastatic renal cell carcinoma—are we ready to roll?
Christian C. Okoye, Ravi B. Patel, Shankar Siva, Alexander V. Louie, Simon S. Lo
Treatment of sepsis-induced acute kidney injury in the ICU: the therapeutic targets do not seem to be established yet
Jean-Pierre Quenot, Auguste Dargent, Audrey Large, Jean-Baptiste Roudaut, Pascal Andreu, Saber Barbar
Safety and delayed intervention rates of active surveillance for small renal masses in an elderly population
Brian T. Kadow, Marc C. Smaldone
The dark side of immunotherapy: challenges facing the new hope in cancer treatment
Eduard Teixidor, Joaquim Bosch-Barrera
Precision surgery for obsessive compulsive disorder—which is the proper target?
Juan Antonio Barcia, Blanca Reneses, Cristina Nombela
Systemic therapy for metastatic renal cell carcinoma—is timing everything?
Ritesh R. Kotecha, Martin H. Voss
Nephrectomy in metastatic renal cell carcinoma with venous thrombus: more thrombus equals less benefit?
Mauricio Burotto, Alex Renner
The importance of not only living longer but also better in the setting of advanced urothelial cancer
Haris Zahoor, Petros Grivas
MRI-based radiosurgical planning: implications in imaging timing
William C. Stross, Timothy D. Malouff, Daniel M. Trifiletti, Laura A. Vallow
Levodopa treatment in Parkinson’s disease: earlier or later?
Federico Paolini Paoletti, Nicola Tambasco, Lucilla Parnetti
The way towards tailored treatment for metastatic renal cancer patients in the omics era: are we getting a “transcriptomic compass”?
Melissa Bersanelli, Alessio Cortellini, Sebastiano Buti
Is survival after sublobar resection vs. lobectomy made equivalent by extent of lymphadenectomy?
Kimberly J. Song, Raja M. Flores
A call for a more rigorous screening of postoperative delirium
Susanne Koch, Finn Radtke, Claudia Spies
New functions assigned to a microRNA with genetic links to prostate cancer risk
Akira Kurozumi, Shawn E. Lupold
Liquid biopsies in renal cell carcinoma with focus on epigenome analysis
Alessia Cimadamore, Matteo Santoni, Francesco Massari, Liang Cheng, Antonio Lopez-Beltran, Marina Scarpelli, Rodolfo Montironi
Implications of the circular RNAs in localized prostate cancer
Shivansh Nigam, Nishat Manzar, Bushra Ateeq
Cytoreductive nephrectomy in patients with metastatic renal cell carcinoma and venous thrombus—trends and effect on overall survival
Aye A. Lwin, Grant R. Pollock, Juan Chipollini
Whole genome sequencing in Mycobacterium tuberculosis
Andrea Spitaleri, Arash Ghodousi, Paolo Miotto, Daniela Maria Cirillo
Bleeding in patients with atrial fibrillation treated with combined antiplatelet and anticoagulant therapy: time to turn the corner
Ke Xu, Noel C. Chan
Stereotactic ablative radiotherapy for early-stage central lung tumors: status, challenges, and future considerations
Ming Li, Cheng Zhan
Suggestions for radiation oncologists to overcome radiotherapy interruption in patients with nasopharyngeal cancer
Jung Ae Lee, Won Sup Yoon
Prolonged albumin administration in patients with decompensated cirrhosis: the amount makes the difference
Manuel Tufoni, Giacomo Zaccherini, Paolo Caraceni
Advocate the implementation of video-assisted thoracoscopic surgery lobectomy program for early stage lung cancer treatment: time to transfer from why to how
Hongbin Zhang, Jens Carsten Rueckert
Biomarkers in metastatic renal cell carcinoma in the era of immune checkpoint inhibitors
Abhishek Tripathi, Edwin Lin, Neeraj Agarwal
Testicular germ cell tumors: the changing role of the pathologist
Andrea Ronchi, Francesca Pagliuca, Renato Franco
The 8th UICC/AJCC TNM edition for non-small cell lung cancer staging: getting off to a flying start?
Andrea Lancia, Elisa Merizzoli, Andrea Riccardo Filippi
Apixaban or rivaroxaban in the treatment of acute venous thromboembolism?
Maja Hellfritzsch, Erik L. Grove, Kasper Adelborg
Vitamin D deficiency and kidney hyperfiltration: a mechanism of kidney injury?
Maya Fakhoury, Rebecca Levy, Michal L. Melamed
MGTX extension study longitudinally favors early thymectomy in non-thymomatous young-adult patients with AChR antibody-positive myasthenia gravis
Tetsuya Akaishi, Masakatsu Motomura, Masashi Aoki, Kimiaki Utsugisawa
GnRH agonist and letrozole in women with recurrent implantation failure
Nidhi Sharma
The importance of timing for the spontaneous breathing trial
Andreas Perren, Laurent Brochard
Avoiding desaturation during endotracheal intubation: is high-flow nasal cannula the answer?
Thais Dias Midega, Guilherme Benfatti Olivato, Fabio Barlem Hohmann, Ary Serpa Neto
Five-year overall survival of pembrolizumab in advanced non-small cell lung cancer: another step from care to cure?
Paolo Bironzo, Francesco Passiglia, Silvia Novello
The use of nephrometry scoring systems can help urologists predict the risk of conversion to radical nephrectomy in patients scheduled for partial nephrectomy
Vincenzo Ficarra, Marta Rossanese, Gianluca Giannarini, Alessandro Crestani, Alchiede Simonato, Antonino Inferrera
Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): are neurologists feeling more comfortable to RESTART antiplatelet?
Tarun Girotra, Wuwei Feng
Are we facing a cure in lung cancer?—KEYNOTE-001 insights
Aharon Y. Cohen, Waleed Kian, Laila C. Roisman, Dina Levitas, Nir Peled, Yulia Dudnik
Nutrition determines outcome after severe burns
Mette M. Berger
Are nephrometry scores enough to select patients really fit for nephron sparing surgery?
Francesco Porpiglia, Daniele Amparore, Angela Pecoraro, Enrico Checcucci
Safety and efficacy of restarting antiplatelet therapy after intracerebral hemorrhage
Mi-Yeon Eun, Jin-Man Jung
Chlorthalidone vs. potassium citrate in a model of hypercalciuria: differential effects on stone and bone
Gianmarco Lombardi, Pietro Manuel Ferraro, Giovanni Gambaro
Clinical glycomics in the diagnostic laboratory
Merel A. Post, Dirk J. Lefeber
Does impaired processing of pro-B-type (or brain) natriuretic peptide cause decreased plasma BNP levels in obese heart failure patients?
Toshio Nishikimi, Yasuaki Nakagawa
Immune-checkpoint inhibitors in brain metastases from renal cell carcinoma: a battle was lost but not the war
Giuseppe Lombardi, Marco Maruzzo, Giuseppe Minniti, Marta Padovan, Mario Caccese, Vittorina Zagonel
A simplified new-generation renal mass complexity scoring system
Ali Hajiran, Ahmet M. Aydin, Salim K. Cheriyan, Wade J. Sexton
Efficacy and safety profiles of mechanical and pharmacological thromboprophylaxis
Mario Ganau, Gianfranco K. I. Ligarotti, Marco Meloni, Salvatore Chibbaro
Integrating mass spectrometry-based plasma (or serum) protein N-glycan profiling into the clinical practice?
Arnaud Bruneel, François Fenaille
Expanding congenital abnormalities of the kidney and urinary tract (CAKUT) genetics: basonuclin 2 (BNC2) and lower urinary tract obstruction
Raul Fernandez-Prado, Mehmet Kanbay, Alberto Ortiz, Maria Vanessa Perez-Gomez
Rapid and accurate diagnosis of hemoglobinopathy and β-thalassemia by ultrahigh-resolution mass spectrometry and tandem mass spectrometry from blood: review of a benchmark study
Laszlo Prokai
Prognostic relevance of tumor response after neoadjuvant therapy for patients with esophageal cancer
Elfriede Bollschweiler, Arnulf H. Hölscher
Cabozantinib in advanced non-clear-cell renal cell carcinoma: is it the way clearer now?
Giulia Di Pierro, Enrico Mini, Giandomenico Roviello
Neoadjuvant androgen deprivation therapy through intense inhibition of the androgen target: “Midsummer Night’s Dream” or “Much Ado About Nothing”?
Alessandro Antonelli, Carlotta Palumbo, Alfredo Berruti
Tumor location does not limit percutaneous treatment of small renal masses with microwave ablation
Xiaosong Meng, Rashed Ghandour, Vitaly Margulis
Is this the ultimate solution to fight erectile dysfunction post radical prostatectomy?
Silvia Secco, Aldo Bocciardi, Mattia Piccinelli, Antonio Galfano
Time to talk about parents of ill children
Yifan Xiang, Erping Long, Zhenzhen Liu, Haotian Lin
Stereotactic ablative radiotherapy for operable stage I non-small cell lung cancer: not ready for prime time
James G. Connolly, Gregory D. Jones, Raul Caso, David R. Jones
VATS lobectomy for early lung cancer: long-term outcomes
Paul A. Toste, Jay M. Lee
Usefulness of the duration of acute kidney injury for predicting renal function recovery after partial nephrectomy
Chang Seong Kim, Eun Hui Bae, Seong Kwon Ma, Soo Wan Kim
Managing intrinsic pro-degradatory mechanical and cellular cycles in the development of osteochondral lesions
Seok Jung Kim, Asode Ananthram Shetty, Saif Ahmed, Neha Shetty, Sang Heon Lee
Is twice better than once?—challenges of troponin measurements for risk prediction in the general population
Henning Jansen, Dietrich Rothenbacher, Wolfgang Koenig
Diagnosis of hemoglobinopathy and β-thalassemia by 21-Tesla Fourier transform ion cyclotron resonance mass spectrometry
Jae-Seok Kim, Hyun Sik Kim
GLP-1 analogue liraglutide as adjunct treatment in diabetes type 2 after failed bariatric/metabolic surgery
Per M. Hellström
Acute kidney injury and long-term renal function after partial nephrectomy—is there a true association?
Won Ho Kim, Hyun-Kyu Yoon, Ho-Jin Lee
Role of lipoprotein (a) in peripheral arterial disease
Constantine E. Kosmas, Delia Silverio, Andreas Sourlas, Richard Peralta, Peter D. Montan, Eliscer Guzman, Mario J. Garcia
Inflammatory proteins in diabetic kidney disease—potential as biomarkers and therapeutic targets
Angie S. Xiang, Elif I. Ekinci, Richard J. MacIsaac


The supplement was published without any sponsorship or funding.